Home › Research › Topics › clinical-value
clinical-value
6 studies tagged clinical-value, dated 2015-12-14 to 2026-05-08. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- The clinical value of multimodal neuroimaging in monoclonal antibody therapy for Alzheimer's disease 2026-05-08
- Clinical value of novel blood-based tau biomarkers in Creutzfeldt-Jakob disease 2024-12-06
- Blood biomarkers for Alzheimer's disease with the Lumipulse automated platform: Age-effect and clinical value interpretation 2024-10-22
Studies
6 studies carry this tag.
Date range
2015 to 2026
Top journals
- Alzheimer's & dementia : the journal of the Alzheimer's Association 1
- Clinica chimica acta; international journal of clinical chemistry 1
- Frontiers in neurology 1
- Journal of neurology, neurosurgery, and psychiatry 1
- Neurology 1
6 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
47/100
Multimodal neuroimaging plays an indispensable role in the diagnosis, monitoring, and therapeutic evaluation of monoclonal antibody (mAb) therapies for Alzheimer's disease (AD).
-
Plasma BD-tau is a valuable marker for CJD prognostication.
-
The specific context of use might be considered to define the cut-offs of blood biomarkers of neurodegenerative diseases.
-
Plasma pTau217 and pTau181 both correlate with AD, but the fold change in pTau217 makes it better to diagnose cerebral amyloidosis, and predict cognitive decline and conversion to AD dementia.
-
57/100
NfL and p/t-tau similarly discriminated FTD from controls, but not between clinical subtypes, apart from FTD-MND.
-
Curcumin derived from turmeric is well documented for its anti-carcinogenic, antioxidant and anti-inflammatory properties.